{"result": "(\"entity\"<|>TRIGLICÉRIDO LIPASA<|>ORGANIZATION<|>Triglicérido lipasa is an enzyme involved in the hydrolysis of triglycerides in the body.)\n##\n(\"entity\"<|>LIPASA SENSIBLE A HORMONAS<|>ORGANIZATION<|>Lipasa sensible a hormonas is an enzyme that plays a role in the breakdown of fats in response to hormonal signals.)\n##\n(\"entity\"<|>MONOGLICÉRIDO LIPASA<|>ORGANIZATION<|>Monoglicérido lipasa is an enzyme that hydrolyzes monoglycerides into glycerol and fatty acids.)\n##\n(\"entity\"<|>VLDL<|>ORGANIZATION<|>Very Low-Density Lipoprotein (VLDL) is a type of lipoprotein that carries triglycerides and cholesterol in the bloodstream.)\n##\n(\"entity\"<|>IDL<|>ORGANIZATION<|>Intermediate-Density Lipoprotein (IDL) is a lipoprotein that is formed from the degradation of VLDL and is involved in lipid transport.)\n##\n(\"entity\"<|>LDL<|>ORGANIZATION<|>Low-Density Lipoprotein (LDL) is a type of lipoprotein that transports cholesterol to cells and is often referred to as \"bad\" cholesterol.)\n##\n(\"entity\"<|>APO B-100<|>ORGANIZATION<|>Apolipoprotein B-100 (Apo B-100) is a protein that is essential for the metabolism of lipoproteins and is a component of LDL.)\n##\n(\"entity\"<|>APO C-II<|>ORGANIZATION<|>Apolipoprotein C-II (Apo C-II) is a protein that acts as a cofactor for lipoprotein lipase, facilitating the breakdown of triglycerides.)\n##\n(\"entity\"<|>APO E<|>ORGANIZATION<|>Apolipoprotein E (Apo E) is a protein involved in the metabolism of fats in the body and is important for the clearance of lipoproteins.)\n##\n(\"entity\"<|>LIPOPROTEÍNA LIPASA<|>ORGANIZATION<|>Lipoprotein lipase (LPL) is an enzyme that hydrolyzes triglycerides in lipoproteins, releasing free fatty acids for use by tissues.)\n##\n(\"entity\"<|>QUILOMICRONES<|>ORGANIZATION<|>Chylomicrons are lipoproteins that transport dietary lipids from the intestines to other locations in the body.)\n##\n(\"entity\"<|>HIDRATOS DE CARBONO<|>ORGANIZATION<|>Carbohydrates are organic compounds that are a major source of energy for the body and are involved in various metabolic processes.)\n##\n(\"entity\"<|>GRASAS TRANS<|>ORGANIZATION<|>Trans fats are a type of unsaturated fat that can have negative health effects and are often found in processed foods.)\n##\n(\"entity\"<|>ÁCIDOS GRASOS MONOINSATURADOS<|>ORGANIZATION<|>Monounsaturated fatty acids are a type of healthy fat found in various foods and oils, beneficial for heart health.)\n##\n(\"entity\"<|>ÁCIDOS GRASOS POLIINSATURADOS<|>ORGANIZATION<|>Polyunsaturated fatty acids are essential fats that the body cannot produce and are important for various bodily functions.)\n##\n(\"entity\"<|>HORMONAS TIROIDEAS<|>ORGANIZATION<|>Thyroid hormones are hormones produced by the thyroid gland that regulate metabolism and energy levels in the body.)\n##\n(\"entity\"<|>GLUCAGÓN<|>ORGANIZATION<|>Glucagon is a hormone produced by the pancreas that raises blood glucose levels by promoting the conversion of glycogen to glucose.)\n##\n(\"entity\"<|>GLUCORTICOIDES<|>ORGANIZATION<|>Glucocorticoids are a class of steroid hormones that play a role in metabolism and immune response regulation.)\n##\n(\"entity\"<|>INSULINA<|>ORGANIZATION<|>Insulin is a hormone produced by the pancreas that regulates blood sugar levels and facilitates the uptake of glucose by cells.)\n##\n(\"entity\"<|>COLESTEROL<|>ORGANIZATION<|>Cholesterol is a waxy substance found in the blood that is essential for building cell membranes and producing hormones.)\n##\n(\"entity\"<|>LIPOPROTEÍNAS DE BAJA DENSIDAD<|>ORGANIZATION<|>Low-Density Lipoproteins (LDL) are a type of lipoprotein that carries cholesterol and triglycerides in the bloodstream.)\n##\n(\"entity\"<|>TRIGLICÉRIDOS<|>ORGANIZATION<|>Triglycerides are a type of fat found in the blood that the body uses for energy.)\n##\n(\"entity\"<|>TEJIDO MUSCULAR<|>ORGANIZATION<|>Muscle tissue is a type of tissue in the body that is responsible for movement and is a major site for energy utilization.)\n##\n(\"entity\"<|>TEJIDO ADIPOSO<|>ORGANIZATION<|>Adipose tissue is a type of connective tissue that stores fat and plays a role in energy balance and metabolism.)\n##\n(\"entity\"<|>HIDRATOS DE CARBONO CON ÍNDICE GLUCÉMICO ELEVADO<|>ORGANIZATION<|>High glycemic index carbohydrates are foods that can cause rapid spikes in blood sugar levels.)\n##\n(\"entity\"<|>ALCOHOL<|>ORGANIZATION<|>Alcohol is a substance that can affect metabolism and energy balance in the body.)\n##\n(\"entity\"<|>OBESIDAD<|>EVENT<|>Obesity is a medical condition characterized by excessive body fat that increases the risk of health problems.)\n##\n(\"entity\"<|>HYPERCHOLESTEROLEMIA<|>EVENT<|>Hypercholesterolemia is a condition characterized by high levels of cholesterol in the blood, increasing the risk of cardiovascular disease.)\n##\n(\"entity\"<|>SÍNTESIS DE HDL<|>EVENT<|>The synthesis of High-Density Lipoprotein (HDL) is a process that helps in the removal of cholesterol from the bloodstream.)\n##\n(\"entity\"<|>CATABOLISMO DE VLDL<|>EVENT<|>The catabolism of Very Low-Density Lipoprotein (VLDL) is a metabolic process that breaks down VLDL into other lipoproteins.)\n##\n(\"entity\"<|>CIRCULACIÓN GENERAL<|>EVENT<|>General circulation refers to the movement of blood throughout the body, delivering nutrients and oxygen to tissues.)\n##\n(\"entity\"<|>RECEPTOR DE LDL<|>ORGANIZATION<|>The LDL receptor is a protein that helps cells take up LDL cholesterol from the bloodstream.)\n##\n(\"entity\"<|>PROTEÍNA RELACIONADA CON EL RECEPTOR DE LDL<|>ORGANIZATION<|>The protein related to the LDL receptor is involved in the metabolism and clearance of lipoproteins from the blood.)\n##\n(\"entity\"<|>RECEPTOR DE LDL<|>ORGANIZATION<|>The LDL receptor is a cell surface receptor that mediates the endocytosis of LDL particles.)\n##\n(\"entity\"<|>MEMBRANA CELULAR<|>ORGANIZATION<|>The cell membrane is a biological membrane that separates and protects the interior of the cell from the external environment.)\n##\n(\"entity\"<|>PROTEOSOMA<|>ORGANIZATION<|>The proteasome is a protein complex that degrades unneeded or damaged proteins by proteolysis.)\n##\n(\"entity\"<|>RETÍCULO ENDOPLÁSMAICO LISO<|>ORGANIZATION<|>The smooth endoplasmic reticulum is an organelle involved in lipid synthesis and metabolism.)\n##\n(\"entity\"<|>CIRCULACIÓN<|>EVENT<|>Circulation refers to the movement of blood through the heart and blood vessels, delivering oxygen and nutrients to tissues.)\n##\n(\"entity\"<|>HIDRÓLISIS<|>EVENT<|>Hydrolysis is a chemical process that involves the breakdown of compounds by the addition of water.)\n##\n(\"entity\"<|>DEGRADACIÓN<|>EVENT<|>Degradation is a biological process that involves the breakdown of complex molecules into simpler ones.)\n##\n(\"entity\"<|>SÍNTESIS<|>EVENT<|>Synthesis is a process in which multiple components combine to form a more complex product.)\n##\n(\"entity\"<|>METABOLISMO LIPÍDICO<|>EVENT<|>Lipid metabolism refers to the processes involved in the synthesis and degradation of lipids in the body.)\n##\n(\"entity\"<|>CATABOLISMO<|>EVENT<|>Catabolism is a metabolic process that breaks down molecules to obtain energy.)\n##\n(\"entity\"<|>TRANSPORTE DE COLESTEROL<|>EVENT<|>Cholesterol transport refers to the movement of cholesterol within the body, primarily through lipoproteins.)\n##\n(\"entity\"<|>RECEPTOR<|>ORGANIZATION<|>A receptor is a protein molecule that receives and responds to signals from outside the cell.)\n##\n(\"entity\"<|>CIRCULACIÓN SANGUÍNEA<|>EVENT<|>Blood circulation is the continuous movement of blood through the heart and blood vessels, supplying oxygen and nutrients to tissues.)\n##\n(\"entity\"<|>CIRCULACIÓN LINFÁTICA<|>EVENT<|>Lymphatic circulation is the movement of lymph through the lymphatic system, which is important for immune function.)\n##\n(\"entity\"<|>CIRCULACIÓN VASCULAR<|>EVENT<|>Vascular circulation refers to the flow of blood through the network of blood vessels in the body.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LÍPIDOS<|>EVENT<|>Lipid circulation refers to the transport of lipids through the bloodstream, primarily in the form of lipoproteins.)\n##\n(\"entity\"<|>CIRCULACIÓN DE TRIGLICÉRIDOS<|>EVENT<|>Triglyceride circulation refers to the movement of triglycerides in the bloodstream, which are transported by lipoproteins.)\n##\n(\"entity\"<|>CIRCULACIÓN DE COLESTEROL<|>EVENT<|>Cholesterol circulation refers to the transport of cholesterol in the bloodstream, primarily by lipoproteins.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPOPROTEÍNAS<|>EVENT<|>Lipoprotein circulation refers to the movement of lipoproteins in the bloodstream, which transport lipids.)\n##\n(\"entity\"<|>CIRCULACIÓN DE ÁCIDOS GRASOS<|>EVENT<|>Fatty acid circulation refers to the transport of fatty acids in the bloodstream, which are released from lipoproteins.)\n##\n(\"entity\"<|>CIRCULACIÓN DE QUILOMICRONES<|>EVENT<|>Chylomicron circulation refers to the movement of chylomicrons in the bloodstream, which transport dietary lipids.)\n##\n(\"entity\"<|>CIRCULACIÓN DE VLDL<|>EVENT<|>VLDL circulation refers to the transport of Very Low-Density Lipoproteins in the bloodstream, which carry triglycerides.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LDL<|>EVENT<|>LDL circulation refers to the movement of Low-Density Lipoproteins in the bloodstream, which transport cholesterol.)\n##\n(\"entity\"<|>CIRCULACIÓN DE IDL<|>EVENT<|>IDL circulation refers to the transport of Intermediate-Density Lipoproteins in the bloodstream, which are formed from VLDL.)\n##\n(\"entity\"<|>CIRCULACIÓN DE HDL<|>EVENT<|>HDL circulation refers to the movement of High-Density Lipoproteins in the bloodstream, which help remove cholesterol.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL ORGANISMO<|>EVENT<|>Lipid circulation in the body refers to the overall transport and metabolism of lipids throughout the body.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL CEREBRO<|>EVENT<|>Lipid circulation in the brain refers to the transport and metabolism of lipids within the central nervous system.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL HÍGADO<|>EVENT<|>Lipid circulation in the liver refers to the processing and metabolism of lipids by the liver.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO<|>EVENT<|>Lipid circulation in adipose tissue refers to the storage and release of lipids in fat tissue.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO MUSCULAR<|>EVENT<|>Lipid circulation in muscle tissue refers to the utilization of lipids for energy in muscle cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO CARDÍACO<|>EVENT<|>Lipid circulation in cardiac tissue refers to the metabolism of lipids in heart cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO HEPÁTICO<|>EVENT<|>Lipid circulation in hepatic tissue refers to the processing of lipids by liver cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO PERIFÉRICO<|>EVENT<|>Lipid circulation in peripheral tissue refers to the transport and metabolism of lipids in tissues outside the central organs.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO CEREBRAL<|>EVENT<|>Lipid circulation in cerebral tissue refers to the transport and metabolism of lipids in the brain.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO NEURONAL<|>EVENT<|>Lipid circulation in neuronal tissue refers to the metabolism of lipids in nerve cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO GLIAL<|>EVENT<|>Lipid circulation in glial tissue refers to the transport and metabolism of lipids in supporting cells of the nervous system.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO MUSCULAR ESTRIADO<|>EVENT<|>Lipid circulation in striated muscle tissue refers to the utilization of lipids for energy in skeletal muscle.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO MUSCULAR LISO<|>EVENT<|>Lipid circulation in smooth muscle tissue refers to the metabolism of lipids in smooth muscle cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO Y MUSCULAR<|>EVENT<|>Lipid circulation in adipose and muscle tissue refers to the storage and utilization of lipids in fat and muscle cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO Y HEPÁTICO<|>EVENT<|>Lipid circulation in adipose and hepatic tissue refers to the processing and storage of lipids in fat and liver cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO Y CEREBRAL<|>EVENT<|>Lipid circulation in adipose and cerebral tissue refers to the transport and metabolism of lipids in fat and brain cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO Y NEURONAL<|>EVENT<|>Lipid circulation in adipose and neuronal tissue refers to the metabolism of lipids in fat and nerve cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO Y GLIAL<|>EVENT<|>Lipid circulation in adipose and glial tissue refers to the transport and metabolism of lipids in fat and supporting cells of the nervous system.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO Y MUSCULAR ESTRIADO<|>EVENT<|>Lipid circulation in adipose and striated muscle tissue refers to the storage and utilization of lipids in fat and skeletal muscle cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO Y MUSCULAR LISO<|>EVENT<|>Lipid circulation in adipose and smooth muscle tissue refers to the metabolism of lipids in fat and smooth muscle cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO Y HEPÁTICO Y MUSCULAR<|>EVENT<|>Lipid circulation in adipose, hepatic, and muscle tissue refers to the processing and utilization of lipids in fat, liver, and muscle cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO Y HEPÁTICO Y CEREBRAL<|>EVENT<|>Lipid circulation in adipose, hepatic, and cerebral tissue refers to the transport and metabolism of lipids in fat, liver, and brain cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO Y HEPÁTICO Y NEURONAL<|>EVENT<|>Lipid circulation in adipose, hepatic, and neuronal tissue refers to the metabolism of lipids in fat, liver, and nerve cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO Y HEPÁTICO Y GLIAL<|>EVENT<|>Lipid circulation in adipose, hepatic, and glial tissue refers to the transport and metabolism of lipids in fat, liver, and supporting cells of the nervous system.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TEJIDO ADIPOSO Y HEPÁTICO Y MUSCULAR ESTRIADO<|>EVENT<|>Lipid circulation in adipose, hepatic, and striated muscle tissue refers to the storage and utilization of lipids in fat, liver, and skeletal muscle cells.)\n##\n(\"entity\"<|>CIRCULACIÓN DE LIPIDOS EN EL TE", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: proteína\n         moléculas de ácidos grasos libres para ser utilizadas como fuente de energía. En la hidró-                                                    de transferencia de triglicéridos          (MTP) en el retículo endoplásmico              liso.  Las  partículas de\n                                                                                                                                                       apo B-100 que no se unen a lípidos se combinan con ubicuitina y se degradan en el proteosoma.\n         lisis intervienen distintas lipasas: triglicérido lipasa, lipasa sensible a hormonas y mono-\n         glicérido lipasa. Está controlada por varias hormonas que actúan a través de receptores                                                       Las VLDL se segregan a la circulación donde son hidrolizadas por la lipoproteína lipasa\n         acoplados a proteínas G. Entre los inductores de lipólisis se encuentran las catecolaminas,                                                   (LPL) y la lipasa hepática y transformadas en IDL. Por otro lado, y al igual que ocurre con\n         el glucagón, los glucocorticoides y las hormonas tiroideas. La insulina es un potente inhi-                                                   los quilomicrones, el catabolismo de VLDL es una vía de síntesis de HDL.\n         bidor de la lipólisis.                                                                                                                        Quilomicrones\n         Referencias:                                                                                                                                  Los quilomicrones se sintetizan en los enterocitos a partir de los ácidos grasos de la dieta,\n         • Orea Soler I, Illán Gómez F. Manual de Endocrinología y Nutrición [Internet]. Madrid: Sociedad Española de Endocrinología y Nutrición;      pasan desde el intestino a la linfa del conducto torácico y de allí a la circulación general.\n           2019. Capítulo 123. Metabolismo lipídico en el individuo sano; [citado 11 de noviembre de 2019]. Disponible en: https://manual.seen.\n           es/article?id=55115048-8138-4e9f-b2ce-4b97ac18103c                                                                                          Durante su circulación actúa sobre ellos la LPL del endotelio vascular liberando ácidos\n\n\n\n466                                                                                                                                                                                                                                                                            467\n---\n                                                                                                                                                                                                                   OBESIDAD,               LÍPIDOS                      8\n                                                                                                                                                                                       Y TRASTORNOS ELECTROLÍTICOS\n\n\n\n         grasos libres a los tejidos para su uso (tejido muscular) y para su almacenamiento (tejido                                                debería derivar de los ácidos grasos monoinsaturados y de los poliinsaturados ω-3 y ω-6\n         adiposo). La LPL necesita para su activación a apo C-II como cofactor. Como consecuencia de                                               (si bien el consumo         de  estos últimos debería         ser inferior al    10% de las      calorías totales,\n         la pérdida de triglicéridos, se transforman en quilomicrones remanentes que dependen de                                                   por su conocido efecto deletéreo en la peroxidación de las lipoproteínas y el descenso del\n         apo E para su eliminación del plasma por el receptor de LDL o por la proteína relacionada                                                 colesterol HDL que provocan). Por sus efectos nocivos sobre la salud cardiovascular en ge-\n         con el receptor de LDL (LRP), puesto que la apo B-48 carece de los aminoácidos responsa-                                                  neral y los lípidos plasmáticos, se debería reducir al máximo las grasas trans. Con respecto\n         bles de la unión al receptor de LDL.                                                                                                      al resto de grasas, las saturadas deberían constituir menos del 10% de las calorías totales\n         Lipoproteínas de baja densidad (LDL)                                                                                                      (<7% en los sujetos hipercolesterolémicos) y el colesterol debería ser inferior a 300 mg/día.\n                                                                                                                                                   En las situaciones en las que las concentraciones de triglicéridos son superiores a\n         Las LDL son el producto final de la cascada metabólica VLDL-IDL-LDL. Tienen una sola mo-                                                  1.000 mg/dl, las grasas deben restringirse a menos del 10% de las kilocalorías ingeridas,\n         lécula de apo B-100 y su componente lipídico está formado mayoritariamente por ésteres                                                    siendo también en estas situaciones necesario suprimir el consumo de hidratos de carbono\n         de colesterol. La función de las LDL es el transporte de colesterol a las células, tanto he-                                              con un índice glucémico elevado. El consumo moderado de alcohol (20 g en hombres y 10 g\n         páticas como de tejidos periféricos. En su captación interviene el receptor de las LDL, que                                               en mujeres) es aceptable; sin embargo, este debe suprimirse totalmente, en caso de hiper-\n         reconoce apo B-100 y apo E. Este receptor se sintetiza por múltiples tipos de células y es                                                trigliceridemia. El aporte energético total deberá reducirse, si existe sobrepeso u obesidad.\n         transportado a la membrana\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>OREA SOLER I<|>PERSON<|>Orea Soler I is an author of a manual on endocrinology and nutrition published in Madrid by the Spanish Society of Endocrinology and Nutrition in 2019.)\n##\n(\"entity\"<|>ILLÁN GÓMEZ F.<|>PERSON<|>Illán Gómez F. is a co-author of a manual on endocrinology and nutrition published in Madrid by the Spanish Society of Endocrinology and Nutrition in 2019.)\n##\n(\"entity\"<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>ORGANIZATION<|>The Spanish Society of Endocrinology and Nutrition is an organization that published a manual on lipid metabolism in healthy individuals in 2019.)\n##\n(\"entity\"<|>MADRID<|>GEO<|>Madrid is the capital of Spain where the manual on endocrinology and nutrition was published.)\n##\n(\"entity\"<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>EVENT<|>The Manual of Endocrinology and Nutrition is a publication that includes information on lipid metabolism and dietary recommendations.)\n##\n(\"relationship\"<|>OREA SOLER I<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Orea Soler I is one of the authors of the Manual of Endocrinology and Nutrition<|>8)\n##\n(\"relationship\"<|>ILLÁN GÓMEZ F.<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Illán Gómez F. is a co-author of the Manual of Endocrinology and Nutrition<|>8)\n##\n(\"relationship\"<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>MANUAL DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>The Spanish Society of Endocrinology and Nutrition published the Manual of Endocrinology and Nutrition<|>9)\n##\n(\"relationship\"<|>OREA SOLER I<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Orea Soler I is associated with the Spanish Society of Endocrinology and Nutrition as an author of their manual<|>7)\n##\n(\"relationship\"<|>ILLÁN GÓMEZ F.<|>SOCIEDAD ESPAÑOLA DE ENDOCRINOLOGÍA Y NUTRICIÓN<|>Illán Gómez F. is associated with the Spanish Society of Endocrinology and Nutrition as a co-author of their manual<|>7)\n<|COMPLETE|>"}]}